Functional antagonism of IL-1α induced gene expression profiles define the cAMP/PKA pathway as a unique regulator of IL-1α signaling networks

References

• McCulloch CA, Downey GP, El-Gabalawy E. Signalling platforms that modulate the inflammatory response: new targets for drug development. Nat Rev Drug Discov (2006), 5, 864–876.
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Biologic basis for interleukin-1 in disease. Blood (1996), 87, 2095–2147.
   PubMed Web of Science ®Google Scholar
• Martin MU, Wesche H. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. Biochim Biophys Acta (2002), 1592, 265–280.
   PubMed Web of Science ®Google Scholar
• Dunne A, O’Neill LA. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci STKE (2003), 171, re3.
   Google Scholar
• O’Neill LA, Dinarello CA. The IL-1α receptor/toll-like receptor superfamily: crucial receptors for inflammation and host defense. Immunol Today (2000), 21, 206–209.
   PubMedGoogle Scholar
• Jindal SK, Agarwal R. Autoimmunity and interstitial lung disease. Curr Opin Pulm Med (2005), 11, 438–446.
   PubMed Web of Science ®Google Scholar
• Dayer JM, Bresnihan B. Targeting interleukin-1 in the treatment of rheumatoid arthritis. Arthritis Rheum (2002), 46, 574–578.
   PubMed Web of Science ®Google Scholar
• Chung KF. Inflammatory mediators in chronic obstructive pulmonary disease. Curr Drug Targets Inflamm Allergy (2005), 4, 619–625.
   PubMedGoogle Scholar
• Serlin DM, Kuang PP, Subramanian M, O’Regan A, Li X, Berman JS, Goldstein RH. Interleukin-1beta induces osteopontin expression in pulmonary fibroblasts. J Cell Biochem (2006), 97, 519–529.
   PubMed Web of Science ®Google Scholar
• Antonelli A, Lapucci G, Vigneti E, Bonini S, Aloe L. Human lung fibroblast response to NGF, IL-1beta, and dexamethsone. Lung (2005), 183, 337–351.
   PubMed Web of Science ®Google Scholar
• Sasaki M, Kashima M, Ito T, Watanabe A, Izumiyama N, Sano M, Kagaya M, Shioya T, Miura M. Differential regulation of metalloproteinase production, proliferation and chemotaxis of human lung fibroblasts by PDGF, interleukin-1beta and TNF-alpha. Mediators Inflamm (2000), 9, 155–160.
   PubMed Web of Science ®Google Scholar
• Ingram JL, Rice AB, Geisenhoffer K, Madtes DK, Bonner JC. IL-13 and IL-1beta promote lung fibroblast growth through coordinated up-regulation of PDGF-AA and PDGF-Ralpha. FASEB J (2004), 18, 1132–1144.
   PubMed Web of Science ®Google Scholar
• Iwasaki K, Noguchi K, Ishikawa I. Prostaglandin E2 and I2 regulate intercellular adhesion molecule-1 expression in interleukin-1 beta-stimulated human gingival fibroblasts. J Periodontal Res (1999), 34, 97–104.
   PubMed Web of Science ®Google Scholar
• Zhu YK, Liu XD, Skold MC, Umino T, Wang H, Romberger DJ, Spurzem JR, Kohyama T, Wen FQ, Rennard SI. Cytokine inhibition of fibroblast-induced gel contraction is mediated by PGE(2) and NO acting through separate parallel pathways. Am J Respir Cell Mol Biol (2001), 25, 245–253.
   PubMed Web of Science ®Google Scholar
• Kohyama T, Liu X, Wen FQ, Kobayashi T, Fang Q, Abe S, Cieslinski L, Barnette MS, Rennard SI. Cytokines modulate cilomilast response in lung fibroblasts. Clin Immunol (2004), 111, 297–302.
   PubMed Web of Science ®Google Scholar
• Dastidar SG, Rajagopal D, Ray A. Therapeutic benefit of PDE4 inhibitors in inflammatory diseases. Curr Opin Investig Drugs (2007), 8, 364–372.
   PubMed Web of Science ®Google Scholar
• Chung KF. Phosphodiesterase inhibitors in airways disease. Eur J Pharmacol (2006), 533, 110–117.
   PubMed Web of Science ®Google Scholar
• Huang S, Wettlaufer SH, Hogaboam C, Aronoff DM, Peters-Golden M. Prostaglandin E(2) inhibits collagen expression and proliferation in patient-derived normal lung fibroblasts via E prostanoid 2 receptor and cAMP signaling. Am J Physiol Lung Cell Mol Physiol (2007), 292, L405–413.
   PubMed Web of Science ®Google Scholar
• Kamio K, Liu X, Sugiura H, Togo S, Kobayashi T, Kawasaki S, Wang X, Mao L, Ahn Y, Hogaboam C, Toews ML, Rennard SI. Prostacyclin analogs inhibit fibroblast contraction of collagen gels through the cAMP-PKA pathway. Am J Respir Cell Mol Biol (2007), 37, 113–120.
   PubMed Web of Science ®Google Scholar
• Cruz-Gervis R, Stecenko AA, Dworski R, Lane KB, Loyd JE, Pierson R, King G, Brigham KL. Altered prostanoid production by fibroblasts cultured from the lungs of human subjects with idiopathic pulmonary fibrosis. Respir Res (2002), 3, 17.
   PubMed Web of Science ®Google Scholar
• Liu X, Sun SQ, Ostrom RS. Fibrotic lung fibroblasts show blunted inhibition by cAMP due to deficient cAMP response element-binding protein phosphorylation. J Pharmacol Exp Ther (2005), 315, 678–687.
   PubMed Web of Science ®Google Scholar
• Liu X, Ostrom RS, Insel PA. cAMP-elevating agents and adenylyl cyclase overexpression promote an antifibrotic phenotype in pulmonary fibroblasts. Am J Physiol Cell Physiol (2004), 286, C1089–1099.
   PubMed Web of Science ®Google Scholar
• Chan-Hui PY, Stephens K, Warnock RA, Singh S. Applications of eTag trade mark assay platform to systems biology approaches in molecular oncology and toxicology studies. Clin Immunol (2004), 111, 162–174.
   PubMed Web of Science ®Google Scholar
• Tullai JW, Schaffer ME, Mullenbrock S, Kasif S, Cooper GM. Identification of transcription factor binding sites upstream of human genes regulated by the phosphatidylinositol 3-kinase and MEK/ERK signaling pathways. J Biol Chem (2004), 279, 20167–20177.
   PubMed Web of Science ®Google Scholar
• Bos JL. Epac proteins: multi-purpose cAMP targets. Trends Biochem Sci (2006), 31, 680–686.
   PubMed Web of Science ®Google Scholar
• Luttrell LM. Composition and function of G protein-coupled receptor signalsomes controlling mitogen-activated protein kinase activity. J Mol Neurosci (2005), 26, 253–264.
   PubMed Web of Science ®Google Scholar
• Marinissen MJ, Gutkind JS. G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol Sci (2001), 22, 368–376.
   PubMed Web of Science ®Google Scholar
• Waters C, Pyne S, Pyne NJ. The role of G-protein coupled receptors and associated proteins in receptor tyrosine kinase signal transduction. Semin Cell Dev Biol (2004), 15, 309–323.
   PubMed Web of Science ®Google Scholar
• Ma L, Pei G. Beta-arrestin signaling and regulation of transcription. J Cell Sci (2007), 120, 213–218.
   PubMed Web of Science ®Google Scholar
• Gao H, Sun Y, Wu Y, Luan B, Wang Y, Qu B, Pei G. Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways. Mol Cell (2004), 14, 303–317.
   PubMed Web of Science ®Google Scholar
• Ye RD. Regulation of nuclear factor kappaB activation by G-protein-coupled receptors. J Leukoc Biol (2001), 70, 839–848.
   PubMed Web of Science ®Google Scholar
• Parry GC, Mackman N. Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-kappaB-mediated transcription. J Immunol (1997), 159, 5450–5456.
   PubMed Web of Science ®Google Scholar
• Fliri AF, Loging WT, Thadeio PF, Volkmann RA. Biological spectra analysis: Linking biological activity profiles to molecular structure. Proc Natl Acad Sci USA (2005), 102, 261–266.
   PubMed Web of Science ®Google Scholar
• Perlman ZE, Slack MD, Feng Y, Mitchison TJ, Wu LF, Altschuler SJ. Multidimensional drug profiling by automated microscopy. Science (2004), 306, 1194–1198.
   PubMed Web of Science ®Google Scholar
• MacDonald ML, Lamerdin J, Owens S, Keon BH, Bilter GK, Shang Z, Huang Z, Yu H, Dias J, Minami T, Michnick SW, Westwick JK. Identifying off-target effects and hidden phenotypes of drugs in human cells. Nat Chem Biol (2006), 2, 329–337.
   PubMed Web of Science ®Google Scholar
• Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet JP, Subramanian A, Ross KN, Reich M, Hieronymus H, Wei G, Armstrong SA, Haggarty SJ, Clemons PA, Wei R, Carr SA, Lander ES, Golub TR. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science (2006), 313, 1929–1935.
   PubMed Web of Science ®Google Scholar
• Plavec I, Sirenko O, Privat S, Wang Y, Dajee M, Melrose J, Nakao B, Hytopoulos E, Berg EL, Butcher EC. Method for analyzing signaling networks in complex cellular systems. Proc Natl Acad Sci USA (2004), 101, 1223–1228.
   PubMed Web of Science ®Google Scholar
• Kunkel EJ, Plavec I, Nguyen D, Melrose J, Rosler ES, Kao LT, Wang Y, Hytopoulos E, Bishop AC, Bateman R, Shokat KM, Butcher EC, Berg EL. Rapid structure-activity and selectivity analysis of kinase inhibitors by BioMAP analysis in complex human primary cell-based models. Assay Drug Dev Technol (2004), 2, 431–441.
   PubMed Web of Science ®Google Scholar
• Berg EL, Kunkel EJ, Hytopoulos E, Plavec I. Characterization of compound mechanisms and secondary activities by BioMAP analysis. J Pharmacol Toxicol Methods (2006), 53, 67–74.
   PubMedGoogle Scholar
• Papoian R, Scherer A, Saulnier M, Staedtler F, Cordier A, Legay F, Maurer G, Staeheli J, Vonderscher J, Chibout SD. VeloceGenomics: an accelerated in vivo drug discovery approach to rapidly predict the biologic, drug-like activity of compounds, proteins, or genes. Pharm Res (2005), 22, 1597–1613.
   PubMed Web of Science ®Google Scholar
• Butcher EC. Can cell systems biology rescue drug discovery? Nat Rev Drug Discov (2005), 4, 461–467.
   PubMed Web of Science ®Google Scholar
• Fishman MC, Porter JA. A new grammar for drug discovery. Nature (2005), 437, 491–493.
   PubMed Web of Science ®Google Scholar
• Apic G, Ignjatovic T, Boyer S, Russell RB. Illuminating drug discovery with biological pathways. FEBS Lett (2005), 579, 1872–1877.
   PubMed Web of Science ®Google Scholar
• Zimmermann GR, Lehar J, Keith CT. Multi-target therapeutics: when the whole is greater than the sum of the parts. Drug Discov Today (2007), 12, 34–42.
   PubMed Web of Science ®Google Scholar
• Nevins JR, Potti A. Mining gene expression profiles: expression signatures as cancer phenotypes. Nat Rev Genet (2007), 8, 601–609.
   PubMed Web of Science ®Google Scholar
• Endoh H, Tomida S, Yatabe Y, Konishi H, Osada H, Tajima K, Kuwano H, Takahashi T, Mitsudomi T. Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction. J Clin Oncol (2004), 22, 811–819.
   PubMed Web of Science ®Google Scholar
• Beene DL, Scott JD. A-kinase anchoring proteins take shape. Curr Opin Cell Biol (2007), 19, 192–198.
   PubMed Web of Science ®Google Scholar
• Cooper DM. Compartmentalization of adenylate cyclase and cAMP signalling. Biochem Soc Trans (2005), 33, 1319–1322.
   PubMed Web of Science ®Google Scholar